Biotech

R&D

Partner Content

ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summi...

Collaborate, license, and partner to reduce risks, validate technologies, and acquire clinically ready assets

News

David Kendall, chief medical officer at Zealand Pharma

Zealand Pharma rakes in $1bn in funding for obesity drugs

Fresh from reporting encouraging results with its obesity drug candidate petrelintide, Zealand Pharma has raised an impressive $1 billion from a new share offering.

News

EvolutionaryScale emerges with $142m for AI drug discovery

Former Meta researchers working on artificial intelligence (AI) and large language models (LLMs) to find protein drugs have banded together to form a start-up called EvolutionaryScale.

News

Marea’s $190m double round heads latest biotech financings

Our latest round-up of biotech financings includes nine-figure rounds for Marea, Santa Ana Bio, and Opthea, with InduPro, Elion, and iOnctura also in on the action.

News

Radiopharma firm Telix abandons Nasdaq listing plans

Just days after Telix priced a $200 million initial public offering (IPO) in the US, the Australian radiopharmaceutical specialist has abandoned the plan.

News

ADC developer Pheon raises $120m, and other bio financings

This week’s round-up of biotech financings is led by a $120 million round for UK-based antibody-drug conjugate (ADC) developer Pheon, with SixPeaks also pulling in nine fi

ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summi...

Zealand Pharma rakes in $1bn in funding for obesity drugs

EvolutionaryScale emerges with $142m for AI drug discovery

Marea’s $190m double round heads latest biotech financings

Radiopharma firm Telix abandons Nasdaq listing plans

ADC developer Pheon raises $120m, and other bio financings

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Biotech

Editor's Picks